Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mason

Showing results (1291-1300 of 1,358) with videos related to

Pageof 136
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2025
Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedureJonas Willmann, Joost J C Verhoeff, Orit Kaidar-Person, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumorsW P Mason, A Grovas, S Halpern, et al.
Neuro-Oncology|June 14, 2018
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placeboBenjamin M Ellingson, Lauren E Abrey, Josep Garcia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junctionMichael J McNamara, David J Adelstein, Joanna W Bodmann, et al.
Journal of Geophysical Research. Planets|July 22, 2022
Vertical Aerosol Distribution and Mesospheric Clouds From ExoMars UVISPaul M Streeter, Graham Sellers, Michael J Wolff, et al.
Plos One|August 14, 2013
Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical modelJennifer S Dickey, Yanira Gonzalez, Baikuntha Aryal, et al.
Journal of Natural Products|March 21, 2020
Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated HypoxiaBlake A Winn, Laxman Devkota, Bunnarack Kuch, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 31, 2023
Underrepresentation of women in exercise science and physiology research is associated with authorship genderJessica J James, Emilie A Klevenow, Mira A Atkinson, et al.
Cancers|March 13, 2025
Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in MiceHashini I Wanniarachchi, Regan Schuetze, Yuling Deng, et al.
Anaesthesia|December 4, 2019
An international multidisciplinary consensus statement on fasting before procedural sedation in adults and childrenS M Green, P L Leroy, M G Roback, et al.
Pageof 136

Showing results (1291-1300 of 1,358) with videos related to

Sort By:
Pageof 136
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2025
Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedureJonas Willmann, Joost J C Verhoeff, Orit Kaidar-Person, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumorsW P Mason, A Grovas, S Halpern, et al.
Neuro-Oncology|June 14, 2018
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placeboBenjamin M Ellingson, Lauren E Abrey, Josep Garcia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junctionMichael J McNamara, David J Adelstein, Joanna W Bodmann, et al.
Journal of Geophysical Research. Planets|July 22, 2022
Vertical Aerosol Distribution and Mesospheric Clouds From ExoMars UVISPaul M Streeter, Graham Sellers, Michael J Wolff, et al.
Plos One|August 14, 2013
Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical modelJennifer S Dickey, Yanira Gonzalez, Baikuntha Aryal, et al.
Journal of Natural Products|March 21, 2020
Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated HypoxiaBlake A Winn, Laxman Devkota, Bunnarack Kuch, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 31, 2023
Underrepresentation of women in exercise science and physiology research is associated with authorship genderJessica J James, Emilie A Klevenow, Mira A Atkinson, et al.
Cancers|March 13, 2025
Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in MiceHashini I Wanniarachchi, Regan Schuetze, Yuling Deng, et al.
Anaesthesia|December 4, 2019
An international multidisciplinary consensus statement on fasting before procedural sedation in adults and childrenS M Green, P L Leroy, M G Roback, et al.
Pageof 136